NovaBay Pharmaceuticals Inc (NBY) stock news · $51.9M cap
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
This NBY news page leads with what NovaBay Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for NBY yet. We will not pad this page with generic market recap.
Latest reported NBY revenue for 2026-06-30 was $2.2M. Net income was -$41.1M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. NBY currently screens at market cap $51.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NBY stock page; for the tape open the quote page.
NBY stock news FAQ
What are NBY's latest revenue and net income?
Latest cached NovaBay Pharmaceuticals Inc (NBY) revenue for Jun 30, 2026 was $2.2M. Net income was -$41.1M. Statements: https://lician.com/financials/nby
How did NBY revenue change from the prior cached period?
Cached NovaBay Pharmaceuticals Inc (NBY) revenue was down 10.4% from $2.5M (Mar 31, 2026) to $2.2M (Jun 30, 2026). Statements: https://lician.com/financials/nby
What is NBY's market cap?
NovaBay Pharmaceuticals Inc (NBY) market cap is $51.9M on the latest cached fundamentals snapshot.
What kind of company is NBY?
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Where is NBY stock news listed?
Cached stock news for NovaBay Pharmaceuticals Inc (NBY) is listed at https://lician.com/news/nby. Filings: https://lician.com/sec/nby
Not investment advice.